Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

Conclusions
The prevalence of HPV 16 and/or 18 was high in all UK countries and highest in those diagnosed at a younger age. The UK is well placed to monitor the impact of HPV vaccination on type-specific HPV prevalence in cervical disease.

Source: Journal of Clinical Pathology - January 20, 2015 Category: Pathology Authors: Mesher, D., Cuschieri, K., Hibbitts, S., Jamison, J., Sargent, A., Pollock, K. G., Powell, N., Wilson, R., McCall, F., Fiander, A., Soldan, K. Tags: Immunology (including allergy), Cervical cancer, Cervical screening, Gynecological cancer Original article Source Type: research